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The global disruptions caused by the coronavirus disease 2019 crisis posed a threat to themomentum the vector
control team at the Liverpool School of Tropical Medicine (LSTM) and the Programme National de Lutte contre
la Tryaponosomiase Humaine Africaine (PNLTHA) had built in their efforts to control tsetse fly populations in the
Democratic Republic of Congo. But despite the pandemic and global lockdown, field activities did continue and
the same impressive results in tsetse fly reduction were observed and the team followed this by completing
a round of ‘tiny target’ deployment without any external presence. Such a success was possible due to the
investment in vector control capacity strengthening undertaken by the LSTM and PNLTHA.
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Introduction
The coronavirus disease 2019 (COVID-19) pandemic has had an
unprecedented impact around the world with health systems
struggling to cope. The pandemic has the potential to inflict
severe disruption in low- and middle-income countries (LMICs)
where health systems are already fragile and it will inevitably
impact on neglected tropical disease (NTD) programmes.1 For
many NTDs, 2020 was an important year, with several elimi-
nation targets to be reached as described in the 2012 World
Health Organization (WHO) NTD road map.2 In response to the
pandemic, the WHO advised that community-based surveys,
mass drug administration and active case finding for NTDs
should be temporarily suspended but recommended that vector
control activities continue.3 Despite the challenges being faced,
we report on some positive developments in vector control from
the Democratic Republic of Congo (DRC).
Historically, vector control for Gambian human African try-
panosomiasis (GHAT) did not form a major part of efforts to con-
trol the disease due to the costs and logistics associated with
available technologies. Consequently the disease was controlled
primarily by large-scale screening and treatment. That situation
changed with the development of ‘tiny targets’, small blue and
black screens impregnated with insecticide that attract and kill
tsetse flies. The technology is in use in Chad, Côte d’Ivoire, Guinea
and Uganda and has been shown to significantly reduce tsetse
populations and disease incidence.4 In 2015, tiny targets were
introduced to the DRC through a pilot project between the Liv-
erpool School of Tropical Medicine (LSTM) and the Programme
National de Lutte contre la Tryaponosomiase Humaine Africaine
(PNLTHA).Working initially in the health zone of Yasa Bonga in the
former Province of Bandundu, tiny targets were used to reduce
tsetse densities by >85%,5 leading to a scale-up of vector con-
trol activities to complement medical interventions in 11 health
zones, increasing coverage from approximately 2000 km2 to ap-
proximately 12 000 km2.
Prior to the introduction of tiny targets, vector control had not
been done systematically in the DRC and the PNLTHA had only
two vector control staff, both based in Kinshasa. In the initial
pilot study, all field activities were coordinated by the LSTM and
one member of PNLTHA staff. To scale-up tsetse control, and to
have a sustainable vector programme, the need to strengthen
capacity for vector control within the PNLTHA was recognized. A
capacity gap analysis was conducted by the Centre for Capacity
Research at the LSTM and a capacity strengthening action plan
was developed, including actions to strengthen ownership of
the tiny target programme by the PNLTHA and involvement of
province and health zone levels, staff development and recruit-
ment and to update equipment and operational materials.
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COVID lockdown
Since 2019, vector control activities expanded, with activities im-
plemented in five health zones in two provinces, but progress was
threatened by COVID-19. National lockdown policies prevented
LSTM staff from travelling to the DRC to support activities and, in
the DRC, restrictions made it impossible for the Kinshasa PNLTHA
entomologists to support the newly recruited provincial teams.
However, even though the provincial-level teams had never im-
plemented activities without support from either the central level
of the PNLTHA or from the LSTM, they managed to continue the
planned implementation of entomological monitoring in June. To
aid their progress, the LSTM and PNLTHA provided remote training
on the use of a phone app designed for data collection, storage
and monitoring.
Movement restrictions have now eased in the DRC and travel
to the field is possible and the second deployment of tiny tar-
gets for the year has been completed in five health zones. In one
health zone the deployment was implemented without the pres-
ence of staff from the central level in Kinshasa—the first time that
a deployment was locally managed. In the remaining four health
zones, the deployments were completed with support from the
PNLTHA Kinshasa. This is the largest deployment of tiny targets
that has been implemented in theDRCwithout external presence,
with approximately 23 500 tiny targets deployed using traditional
canoes or by foot over approximately 4700 km2.
What can we learn from this experience?
Capacity strengthening for vector control has been crucial for the
continuance of vector control in the DRC. It demonstrated the po-
tential for empowerment and autonomy of local teams to pro-
duce a lasting impact and the sustainability of global health in-
terventions.6,7 If the pandemic had occurred 2 y earlier, it is likely
that the impact on tsetse fly control operations in the DRC would
have been farmore drastic, as there was no vector control capac-
ity outside of Kinshasa. It is due to capacity strengthening that
vector control in the DRC is on its way to amuchmore sustainable
system thanks to the ongoingwork to transition responsibilities to
provincial and health zone levels.
As observed during the Ebola outbreak in Guinea, the COVID-
19 pandemic has demonstrated the resilience of tsetse fly control
in a crisis. In the Ebola outbreak, GHATmedical activities had to be
suspended but tiny target deployment continued andwas shown
to have a significant impact on disease incidence.8 The example
from Guinea highlights the importance of continuing vector con-
trol during crises whenmedical surveys must be put on hold. As a
result of our capacity strengtheningwork, vector control has been
maintained during the COVID-19 pandemic, as recommended by
the WHO,3 providing vital protection to local communities.
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